Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy ; volume:3 ; number:8 ; day:23 ; month:7 ; year:2024 ; pages:1003-1016 ; date:8.2024
Nature cardiovascular research ; 3, Heft 8 (23.7.2024), 1003-1016, 8.2024
- Urheber
-
Hartman, James J.
Hwee, Darren T.
Robert-Paganin, Julien
Chuang, Chihyuan
Chin, Eva R.
Edell, Samantha
Lee, Ken H.
Madhvani, Roshni
Paliwal, Preeti
Pernier, Julien
Sarkar, Saswata Sankar
Schaletzky, Julia
Schauer, Kristine
Taheri, Khanha D.
Wang, Jingying
Wehri, Eddie
Wu, Yangsong
Houdusse, Anne
Morgan, Bradley P.
Malik, Fady I.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s44161-024-00505-0
- URN
-
urn:nbn:de:101:1-2411041107283.493623593155
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hartman, James J.
- Hwee, Darren T.
- Robert-Paganin, Julien
- Chuang, Chihyuan
- Chin, Eva R.
- Edell, Samantha
- Lee, Ken H.
- Madhvani, Roshni
- Paliwal, Preeti
- Pernier, Julien
- Sarkar, Saswata Sankar
- Schaletzky, Julia
- Schauer, Kristine
- Taheri, Khanha D.
- Wang, Jingying
- Wehri, Eddie
- Wu, Yangsong
- Houdusse, Anne
- Morgan, Bradley P.
- Malik, Fady I.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Novel Cardiac Myosin Inhibitor Therapy for Hypertrophic Cardiomyopathy in Adults: A Contemporary Review
β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity
Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition
Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light
Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene
Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene
Analysis of the expression regulation of the human atrial myosin light chain 1 upon hypertrophic stimulation
Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy
Cardiac myosin inhibitor, CK-586, minimally reduces systolic function and ameliorates obstruction in feline hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C
MicroRNA expression profiles in familial hypertrophic cardiomyopathy with myosin-binding protein C3 (MYBPC3) gene mutations
Probing strigolactone perception mechanisms with rationally designed small-molecule agonists stimulating germination of root parasitic weeds
Novel Cardiac Myosin Inhibitor Therapy for Hypertrophic Cardiomyopathy in Adults: A Contemporary Review
β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity
Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition
Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light
Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene
Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene
Analysis of the expression regulation of the human atrial myosin light chain 1 upon hypertrophic stimulation
Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy
Cardiac myosin inhibitor, CK-586, minimally reduces systolic function and ameliorates obstruction in feline hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C
MicroRNA expression profiles in familial hypertrophic cardiomyopathy with myosin-binding protein C3 (MYBPC3) gene mutations
Probing strigolactone perception mechanisms with rationally designed small-molecule agonists stimulating germination of root parasitic weeds
Novel Cardiac Myosin Inhibitor Therapy for Hypertrophic Cardiomyopathy in Adults: A Contemporary Review
β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity
Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition
Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light
Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene
Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene
Analysis of the expression regulation of the human atrial myosin light chain 1 upon hypertrophic stimulation
Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy
Cardiac myosin inhibitor, CK-586, minimally reduces systolic function and ameliorates obstruction in feline hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C
MicroRNA expression profiles in familial hypertrophic cardiomyopathy with myosin-binding protein C3 (MYBPC3) gene mutations